Angiodynamics (ANGO) EBITDA Margin (QoQ) (2010 - 2026)
Analysis
Angiodynamics (ANGO) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 474.00 |
| Feb 28, 2026 | -880.00 |
| Nov 30, 2025 | 636.00 |
| Aug 31, 2025 | -685.00 |
| May 31, 2025 | 663.00 |
| Feb 28, 2025 | 138.00 |
| Nov 30, 2024 | 418.00 |
| Aug 31, 2024 | 95.00 |
| May 31, 2024 | 24,553.00 |
| Feb 29, 2024 | -24,929.00 |
| Nov 30, 2023 | -6,111.00 |
| Aug 31, 2023 | 6,740.00 |
| May 31, 2023 | -1,182.00 |
| Feb 28, 2023 | -156.00 |
| Nov 30, 2022 | 681.00 |
| Aug 31, 2022 | -896.00 |
| May 31, 2022 | -19.00 |
| Feb 28, 2022 | 393.00 |
| Nov 30, 2021 | -56.00 |
| Aug 31, 2021 | 1,757.00 |